LEGN · Legend Biotech Corp ADR
United States · RS rating 32 · As of 2026-10-14
| Price | 19.04 USD |
|---|---|
| 1-day change | +6.5% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 92 / 23 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 19 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +27.3% |
| Sales growth Q/Q | +12.5% |
| Distance from 52-week high | +47.5% |
| Market cap (USD) | $4.4B |